Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2014 Aug 15;106(8):dju156.
doi: 10.1093/jnci/dju156. Print 2014 Aug.

Cardiovascular morbidity and mortality after treatment for ductal carcinoma in situ of the breast

Naomi B Boekel  1 , Michael Schaapveld  1 , Jourik A Gietema  1 , Emiel J T Rutgers  1 , Michel I M Versteegh  1 , Otto Visser  1 , Berthe M P Aleman  1 , Flora E van Leeuwen  2
Affiliations
Comparative Study

Cardiovascular morbidity and mortality after treatment for ductal carcinoma in situ of the breast

Naomi B Boekel et al. J Natl Cancer Inst. .

Abstract

Background: Recent concerns about potential overdiagnosis and overtreatment of ductal carcinoma in situ of the breast (DCIS) render evaluation of late effects of treatment, such as cardiovascular disease (CVD), of great importance. We studied cardiovascular morbidity and mortality in a large population-based cohort of DCIS patients.

Methods: Data on all incident DCIS case patients in the Netherlands between 1989 and 2004 who were diagnosed before the age of 75 years were obtained (n = 10468). CVD data was acquired through linkage with population-based registries. Standardized mortality ratios were calculated by comparing mortality in our cohort with that in the Dutch female population, taking into account person-years of observation. Within-cohort comparisons were based on multivariable competing-risk regression.

Results: Compared with the general population, 5-year survivors of DCIS had a similar risk of dying due to any cause (standardized mortality ratio [SMR] = 1.04; 95% confidence interval [CI] = 0.97 to 1.11) but a lower risk of dying of CVD (SMR = 0.77; 95% CI = 0.67 to 0.89). No difference in CVD risk was found when comparing 5-year survivors treated with radiotherapy with those treated with surgery only. Left-sided vs right-sided radiotherapy also did not increase this risk (hazard ratio [HR] = 0.94; 95% CI = 0.67 to 1.32). In a subgroup analysis of all DCIS patients diagnosed between 1997 and 2005, we were able to account for history of CVD and did not observe a risk difference between treatment groups (left-sided vs right-sided radiotherapy: HR = 0.94; 95% CI = 0.68 to 1.29).

Conclusions: After a median follow-up of 10 years, we did not find an increased risk for cardiovascular morbidity or mortality after radiotherapy for DCIS when comparing surgery and radiotherapy vs surgery only, nor when comparing radiotherapy for left-sided vs right-sided DCIS. Compared with the general population, DCIS patients have a decreased risk of cardiovascular death, independent of treatment.

PubMed Disclaimer

References

    1. Li CI, Daling JR, Malone KE. Age-specific incidence rates of in situ breast carcinomas by histologic type, 1980 to 2001. Cancer Epidemiol Biomarkers Prev. 2005;14(4):1008–1011. - PubMed
    1. Puig-Vives M, Pollan M, Rue M, et al. Rapid increase in incidence of breast ductal carcinoma in situ in Girona, Spain 1983–2007. Breast. 2012;21(5):646–651. - PubMed
    1. Sorum R, Hofvind S, Skaane P, et al. Trends in incidence of ductal carcinoma in situ: the effect of a population-based screening programme. Breast. 2010;19(6):499–505. - PubMed
    1. van Steenbergen LN, Voogd AC, Roukema JA, et al. Screening caused rising incidence rates of ductal carcinoma in situ of the breast. Breast Cancer Res Treat. 2009;115(1):181–183. - PubMed
    1. Virnig BA, Shamliyan T, Tuttle TM, et al. Diagnosis and management of ductal carcinoma in situ (DCIS). Evid Rep Technol Assess. 2009;(185):1–549. - PMC - PubMed

Publication types

MeSH terms